Your browser doesn't support javascript.
loading
Site-Specific Tandem Knoevenagel Condensation-Michael Addition To Generate Antibody-Drug Conjugates.
Kudirka, Romas A; Barfield, Robyn M; McFarland, Jesse M; Drake, Penelope M; Carlson, Adam; Bañas, Stefanie; Zmolek, Wes; Garofalo, Albert W; Rabuka, David.
  • Kudirka RA; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
  • Barfield RM; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
  • McFarland JM; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
  • Drake PM; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
  • Carlson A; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
  • Bañas S; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
  • Zmolek W; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
  • Garofalo AW; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
  • Rabuka D; Catalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
ACS Med Chem Lett ; 7(11): 994-998, 2016 Nov 10.
Article en En | MEDLINE | ID: mdl-27882197
ABSTRACT
Expanded ligation techniques are sorely needed to generate unique linkages for the growing field of functionally enhanced proteins. To address this need, we present a unique chemical ligation that involves the double addition of a pyrazolone moiety with an aldehyde-labeled protein. This ligation occurs via a tandem Knoevenagel condensation-Michael addition. A pyrazolone reacts with an aldehyde to generate an enone, which undergoes subsequent attack by a second pyrazolone to generate a bis-pyrazolone species. This rapid and facile ligation technique is performed under mild conditions in the absence of catalyst to generate new architectures that were previously inaccessible via conventional ligation reactions. Using this unique ligation, we generated three site-specifically labeled antibody-drug conjugates (ADCs) with an average of four drugs to one antibody. The in vitro and in vivo efficacies along with pharmacokinetic data of the site-specific ADCs are reported.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2016 Tipo del documento: Article